Methanol Partition Fraction of Ethanol Extract of Discorea nipponica Makino Inhibits Melanogenesis
Purpose: To investigate the inhibitory effect of the methanol fraction of Dioscorea nipponica Makino ethanol extract (DNM) on melanogenesis both in vitro and in vivo.
Methods: Cultured mouse B16 melanoma cell and zebra fish were used to evaluate the melanogenesis inhibitory activity of DNM in vitro and in vivo, respectively. In B16 cells, inhibitory effects on intracellular melanogenesis, tyrosinase activity and reactive oxygen species (ROS) were determined after DNM treatment. In zebra fish, both toxic and antimelanogenic ctivities of DNM on developed larvae were evaluated.
Results: In B16 cells, the results show that DNM dose-dependently inhibited melanogenesis at non-toxic concentrations. Surprisingly, however, DNM had no effect on intracellular tyrosinase activity or the amount of the enzyme in B16 cells. On the other hand, DNM showed strong antioxidant activities against cell-free 2,2-diphenyl-1-picryl-hydrazl (DPPH) and 2,2’-azino-bis (3-etnylbenzthiazoline-6-sulphaonic acid) (ABTS+) free radical and intracellular ROS in B16 cells. In zebra fish, DNM significantly and dose-dependently inhibited skin melanogenesis of zebra fish larvae at non-toxic concentrations.
Conclusion: The findings demonstrate that DNM inhibits melanogenesis in vitro in B16 melanoma cells and in vivo in zebrafish. Furthermore, DNM exhibits potent inhibition of melanogenesis probably as a result of its antioxidant activity in the cells.
Keywords: Dioscorea nipponica, Makino, Melanogenesis, Tyrosinase, Antioxidant, Melanoma, Zebra fish
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.